Abstract
Objectives : This research investigates the effect of the JCT extract regarding Alzheimer's disease. Methods : The effects of the JCT extract on IL-<TEX>$1{\beta}$</TEX>, IL-6, TNF-<TEX>${\alpha}$</TEX>, COX-2, NOS-II mRNA, APP mRNA, BACE mRNA, Nitric oxide(NO), and <TEX>${\beta}A$</TEX> protein production in the BV2 microglia cell lines treated with LPS and <TEX>${\beta}A$</TEX> were investigated. Results : 1. The JCT extract suppressed the expression of IL-<TEX>$1{\beta}$</TEX>, IL-6, TNF-<TEX>${\alpha}$</TEX>, COX-2, and NOS-II mRNA in BV2 microglial cell line treated with LPS and <TEX>${\beta}A$</TEX>. 2. The JCT extract suppressed the expression of BACE and APP mRNA in BV2 microglial cell line treated with LPS and <TEX>${\beta}A$</TEX>. 3. The JCT extract suppressed the expression of Nitric oxide(NO) in BV2 microglial cell line treated with LPS and <TEX>${\beta}A$</TEX>. 4. The JCT extract suppressed the expression of <TEX>${\beta}A$</TEX> protein production in BV2 microglial cell line treated with LPS and <TEX>${\beta}A$</TEX>. Conclusions : These results suggest that the JCT group may be effective for the treatment of Alzheimer's disease. Thus, JCT could be considered among the future therapeutic drugs indicated for the treatment of Alzheimer's disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.